Melanotan II: α-MSH Receptor Pharmacology and Melanocorti…

Melanotan II: α-MSH Receptor Pharmacology and Melanocortin System Research

Melanotan II is a synthetic α-MSH analogue with broad melanocortin receptor activity. We examine the receptor binding profile, pigmentation biology, and the broader melanocortin system implications for aesthetic and metabolic research.

29 giugno 202610 min read

Amino Acids (Cyclic Lactam)

MC1R–MC5R

Receptor Coverage (Pan-MCR)

D-Phe

Key Potency-Enhancing Substitution

α-MSH

Parent Hormone Structure

The Melanocortin System: A Five-Receptor Network

The melanocortin system is one of the more pharmacologically interesting receptor families in preclinical research. Five receptors (MC1R through MC5R), expressed across a wide range of tissue types, respond to peptide ligands derived from the POMC (proopiomelanocortin) precursor. The natural ligands include α-MSH, β-MSH, γ-MSH, and ACTH — each with distinct receptor selectivity profiles and tissue effects.

Melanotan II (MT-2) is a synthetic cyclic lactam analogue of α-MSH with pan-MCR activity — it binds across all five receptor subtypes, making it a useful pharmacological probe for studying the melanocortin system as a whole, and a reference compound for receptor subtype research when combined with selective antagonists.

Structural Modifications That Define MT-2's Pharmacology

Cyclic Lactam Structure

Cyclisation via an Asp–Lys lactam bridge creates conformational rigidity that restricts the peptide to a β-turn conformation optimal for MCR binding — increasing receptor affinity and metabolic stability vs linear α-MSH.

D-Phe Substitution

Replacing L-Phe at position 7 with D-Phe (D-phenylalanine) dramatically increases potency — D-Phe is a pharmacophore feature that enhances hydrophobic receptor contact. MT-2 is 3–5× more potent than native α-MSH at MC1R.

Nle Substitution

Methionine (Met) replacement with Nle (norleucine) eliminates the sulphur-containing side chain susceptible to oxidation. This improves oxidative stability and shelf-life compared to native α-MSH.

MC4R Hypothalamic Activity

MC4R expression in hypothalamic nuclei mediates appetite and energy expenditure effects. MT-2's MC4R activity makes it a research tool for studying hypothalamic circuits relevant to energy homeostasis.

MC1R and Melanogenesis: The Pigmentation Pathway

MT-2's best-characterised research application is MC1R-mediated melanogenesis. MC1R is expressed on melanocytes — the pigment-producing cells of the skin — and its activation by α-MSH or MT-2 triggers a well-defined signalling cascade: MC1R → cAMP → PKA → CREB phosphorylation → MITF (microphthalmia-associated transcription factor) upregulation → tyrosinase, TRP-1, TRP-2 expression → eumelanin synthesis.

This is the same pathway activated by UV radiation-induced α-MSH release, which is why MT-2 produces melanogenesis in melanocyte cultures and skin darkening in pigmented mouse models without UV exposure. For photoprotection research, this UV-independent melanogenesis is a significant property — it allows study of melanin's UV-protective effects independently of the DNA damage that UV itself causes.

Receptor	Primary Tissue	Research Endpoint
MC1R	Melanocytes, skin	Melanogenesis, eumelanin synthesis, UV protection
MC3R	Hypothalamus, gut	Energy balance, feed-back regulation, adipogenesis
MC4R	Hypothalamus, brainstem	Appetite suppression, energy expenditure, GH axis
MC5R	Exocrine glands	Sebaceous secretion, exocrine biology
MC2R	Adrenal cortex	Not significantly bound by MT-2

Research Applications

MT-2's pan-MCR activity makes it particularly useful as a reference agonist in structure-activity relationship studies for selective MCR subtype compounds. By combining MT-2 with selective antagonists (SHU-9119 for MC3R/MC4R, PG-901 for MC4R), researchers can dissect receptor subtype contributions to specific endpoints.

Composto di ricerca · Solo per uso scientifico

Melanotan II (MT-2)

α-MSH cyclic analogue · ≥99% HPLC purity · Lyophilised

MC1R melanogenesis research
Pan-MCR pharmacology
Hypothalamic circuit studies

Vedi il composto di ricerca

≥99% PurezzaCertificato HPLCSpedizione UESolo ricerca

The Aesthetic Skin Stack: MT-2 + GHK-Cu

The Aesthetic Skin Stack combines Melanotan II with GHK-Cu (glycyl-L-histidyl-L-lysine copper(II)) for research protocols examining both melanogenesis (MT-2 → MC1R → eumelanin) and collagen synthesis (GHK-Cu → TGF-β → Smad2/3 → COL1A1/COL3A1) in the same experimental system. This allows simultaneous assessment of two distinct skin biology pathways relevant to aesthetic dermatology research.

Research Use Only

Melanotan II is a research compound for in vitro and preclinical laboratory use only. No approved therapeutic application exists. Not intended for human administration.

Frequently Asked Questions

What is Melanotan II and how does it differ from native α-MSH?

Melanotan II (MT-2) is a cyclic synthetic lactam analogue of α-melanocyte-stimulating hormone (α-MSH). Native α-MSH is a 13-amino acid peptide derived from POMC (proopiomelanocortin) processing. MT-2 is a shorter 7-amino acid cyclised peptide (Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2) with three key modifications: cyclisation (increased conformational rigidity and metabolic stability), D-Phe substitution at position 7 (improved receptor binding affinity), and Nle substitution for Met (oxidative stability). The result is a compound with significantly higher potency and metabolic stability than native α-MSH.

Which melanocortin receptors does Melanotan II bind to?

Melanotan II is a non-selective melanocortin receptor agonist with activity across MC1R through MC5R. MC1R (melanocytes, skin pigmentation) is responsible for its melanogenesis-stimulating effects. MC3R and MC4R (hypothalamic nuclei) mediate appetite suppression and energy expenditure effects that have made Bremelanotide (a related analogue) clinically relevant. MC4R in the hypothalamus is also associated with the sexual behaviour effects studied in early Melanotan research. MC5R is expressed in exocrine glands and has been studied in the context of dermatological secretion. This broad receptor profile makes MT-2 a useful research tool for pan-melanocortin receptor pharmacology.

What does Melanotan II's melanogenesis research show?

In melanocyte cell culture and rodent skin models, MT-2 activates MC1R, which signals through cAMP/PKA to phosphorylate CREB, upregulating MITF (microphthalmia-associated transcription factor) — the master regulator of melanogenesis. MITF drives expression of tyrosinase, TRP-1, and TRP-2, the key enzymes in eumelanin synthesis. The result is dose-dependent melanin production in melanocyte cultures and increased skin darkening in pigmented mouse models. This pathway is the same as UV-induced tanning, making MT-2 a useful research tool for studying melanogenesis regulation independently of UV radiation.

What are the research applications of Melanotan II beyond pigmentation?

Beyond pigmentation biology, MT-2 research applications include: MC4R pharmacology and appetite regulation (relevant to obesity research intersecting with GLP-1 class compounds), melanocortin receptor structure-activity relationship studies (the rigid cyclic scaffold makes it useful for understanding receptor binding geometry), photoprotection research (increased melanin provides UV protection — relevant to skin cancer prevention research), and dermatological skin quality research when combined with GHK-Cu (the Aesthetic Skin Stack formulation allows combined melanogenesis and collagen synthesis investigation).

Is Melanotan II available as a research peptide for laboratory studies?

Yes. Melanotan II is available as a research-grade synthetic peptide for in vitro and preclinical laboratory research. It is an investigational compound with no approved human therapeutic application. Research applications include melanocortin receptor binding assays, melanogenesis pathway studies in melanocyte cultures, MC4R pharmacology in hypothalamic cell models, and combined skin biology research. VeloxPeptide supplies Melanotan II at ≥99% HPLC purity with a certificate of analysis. It is available both as a standalone compound and as part of the Aesthetic Skin Stack (MT-2 + GHK-Cu) formulation.